FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1799382018> ?p ?o ?g. }

• W1799382018 endingPage "1101" @default.
• W1799382018 startingPage "1101" @default.
• W1799382018 abstract "Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation Takanori Yamamoto,1 Mika Tsujimoto,2 Hideaki Sowa11Medical Science, Lilly Research Laboratories, Medicines Development Unit Japan, 2Asia Pacific Statistical Science-Japan, Science and Regulatory Affairs, LRL MDU-Japan, Eli Lilly Japan K.K, Kobe, Hyogo, JapanObjective: Serum procollagen type I N-terminal propeptide (PINP), a representative marker of bone anabolic action, is strongly related to bone mineral density during teriparatide therapy. This post hoc study analyzed data from a Phase III study (ClinicalTrials.gov identifier NCT00433160) to determine if there was an association between serum PINP elevation and serum calcium concentration or calcium metabolism-related disorders.Research design and methods: Japanese subjects with osteoporosis at high risk of fracture were randomized 2:1 to teriparatide 20 µg/day (n=137) or placebo (n=70) for a 12-month double-blind treatment period, followed by 12 months of open-label teriparatide treatment of all subjects.Main outcome measures: Serum PINP levels were measured at baseline, and after 1, 3, 6, 12, 18, and 24 months of treatment. Serum calcium levels were measured at baseline, and after 1, 3, 6, 9, 12, 15, 18, 21, and 24 months of treatment.Results: Serum PINP increased from baseline to 1 month of treatment and then remained high through 24 months. Twenty-eight of 195 subjects experienced PINP elevations >200 µg/L during teriparatide treatment. Serum calcium concentration in both the teriparatide and placebo groups remained within the normal range. There was no clinically relevant difference in serum calcium concentration between subjects with PINP >200 µg/L and subjects with PINP ≤200 µg/L. Two subjects experienced hypercalcemia and recovered without altering teriparatide treatment. Adverse events possibly related to calcium metabolism disorders included periarthritis calcarea (one subject) and chondrocalcinosis pyrophosphate (two subjects), but neither was accompanied with a significant increase in PINP or serum calcium concentration.Conclusion: Although the moderate size of this study prevented statistical analysis of any potential association between calcium metabolism-related disorders and elevated PINP, this analysis suggests that there was no association between serum PINP elevation during daily teriparatide treatment and serum calcium concentration or calcium metabolism-related disorders in Japanese subjects.Keywords: teriparatide, osteoporosis, hypercalcemia, procollagen type I N-terminal propeptide, bone metabolism markers" @default.
• W1799382018 created "2016-06-24" @default.
• W1799382018 creator A5011995779 @default.
• W1799382018 creator A5025961114 @default.
• W1799382018 creator A5062013397 @default.
• W1799382018 date "2015-07-01" @default.
• W1799382018 modified "2023-09-23" @default.
• W1799382018 title "Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation" @default.
• W1799382018 cites W1834041072 @default.
• W1799382018 cites W1968677875 @default.
• W1799382018 cites W1978341905 @default.
• W1799382018 cites W1979411287 @default.
• W1799382018 cites W1986190669 @default.
• W1799382018 cites W1996035030 @default.
• W1799382018 cites W2014026700 @default.
• W1799382018 cites W2021744135 @default.
• W1799382018 cites W2022975827 @default.
• W1799382018 cites W2062816105 @default.
• W1799382018 cites W2088510337 @default.
• W1799382018 cites W2093944682 @default.
• W1799382018 cites W2101737661 @default.
• W1799382018 cites W2137880068 @default.
• W1799382018 cites W2145794294 @default.
• W1799382018 doi "https://doi.org/10.2147/cia.s83549" @default.
• W1799382018 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4500620" @default.
• W1799382018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26185429" @default.
• W1799382018 hasPublicationYear "2015" @default.
• W1799382018 type Work @default.
• W1799382018 sameAs 1799382018 @default.
• W1799382018 citedByCount "2" @default.
• W1799382018 countsByYear W17993820182016 @default.
• W1799382018 crossrefType "journal-article" @default.
• W1799382018 hasAuthorship W1799382018A5011995779 @default.
• W1799382018 hasAuthorship W1799382018A5025961114 @default.
• W1799382018 hasAuthorship W1799382018A5062013397 @default.
• W1799382018 hasBestOaLocation W17993820181 @default.
• W1799382018 hasConcept C126322002 @default.
• W1799382018 hasConcept C134018914 @default.
• W1799382018 hasConcept C170033053 @default.
• W1799382018 hasConcept C2776541429 @default.
• W1799382018 hasConcept C2776886416 @default.
• W1799382018 hasConcept C2777308945 @default.
• W1799382018 hasConcept C519063684 @default.
• W1799382018 hasConcept C64348721 @default.
• W1799382018 hasConcept C67761136 @default.
• W1799382018 hasConcept C71924100 @default.
• W1799382018 hasConceptScore W1799382018C126322002 @default.
• W1799382018 hasConceptScore W1799382018C134018914 @default.
• W1799382018 hasConceptScore W1799382018C170033053 @default.
• W1799382018 hasConceptScore W1799382018C2776541429 @default.
• W1799382018 hasConceptScore W1799382018C2776886416 @default.
• W1799382018 hasConceptScore W1799382018C2777308945 @default.
• W1799382018 hasConceptScore W1799382018C519063684 @default.
• W1799382018 hasConceptScore W1799382018C64348721 @default.
• W1799382018 hasConceptScore W1799382018C67761136 @default.
• W1799382018 hasConceptScore W1799382018C71924100 @default.
• W1799382018 hasLocation W17993820181 @default.
• W1799382018 hasLocation W17993820182 @default.
• W1799382018 hasLocation W17993820183 @default.
• W1799382018 hasLocation W17993820184 @default.
• W1799382018 hasLocation W17993820185 @default.
• W1799382018 hasOpenAccess W1799382018 @default.
• W1799382018 hasPrimaryLocation W17993820181 @default.
• W1799382018 hasRelatedWork W1967422973 @default.
• W1799382018 hasRelatedWork W1993961484 @default.
• W1799382018 hasRelatedWork W2005091007 @default.
• W1799382018 hasRelatedWork W2030011766 @default.
• W1799382018 hasRelatedWork W2084548911 @default.
• W1799382018 hasRelatedWork W2363054171 @default.
• W1799382018 hasRelatedWork W2582285020 @default.
• W1799382018 hasRelatedWork W2983293648 @default.
• W1799382018 hasRelatedWork W3165227252 @default.
• W1799382018 hasRelatedWork W48344418 @default.
• W1799382018 isParatext "false" @default.
• W1799382018 isRetracted "false" @default.
• W1799382018 magId "1799382018" @default.
• W1799382018 workType "article" @default.